In the cell biology space, we found Sigma-Aldrich and Qiagen to be the most differentiated brands
ARLINGTON, Va. (PRWEB) October 24, 2007
"In the cell biology space, we found Sigma-Aldrich and Qiagen to be the most differentiated brands," said Dr. Tamara Zemlo, Director of Syndicated Research at BioInformatics. "The ultimate goal of our research is to assist companies in these markets to adopt a unique brand positioning strategy that is based on scientists' perceptions of their products."
Key findings of the reports will be shared in a complimentary webinar. The webinar will be presented: Tuesday, October 30 at 11:00 am EDT; Tuesday, November 7 at 1:00 pm EST; and Wednesday, November 28 at 11:00 am EST. To register to attend one of the sessions, please email email@example.com.
Specific companies profiled in detail in this report include: BD Biosciences; Cell Signaling Technology; GE Healthcare; Invitrogen; Pierce Biotechnology; Promega; Qiagen; R&D Systems; Roche Applied Science; and Sigma-Aldrich.
The other five product categories analyzed in related reports are: gene expression and analysis products; instrumentation for genomic analysis; instrumentation for protein analysis; nucleic acid purification products; and protein separation products. These reports examine the leading brands using a variety of models across a '4D' methodology - distinct, desirable, delivery and durable.
For a complimentary Executive Summary of this report, please visit http://www.gene2drug.com/reports.
ABOUT BIOINFORMATICS, LLC
BioInformatics, LLC is the premier research and consulting firm serving the life science industry. By leveraging our global online panel of more than 30,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.